Literature DB >> 23714583

Fractionated radiation-induced nitric oxide promotes expansion of glioma stem-like cells.

Rae-Kwon Kim1, Yongjoon Suh, Yan-Hong Cui, Eunji Hwang, Eun-Jung Lim, Ki-Chun Yoo, Ga-Haeng Lee, Joo-Mi Yi, Seok-Gu Kang, Su-Jae Lee.   

Abstract

Glioblastoma remains an incurable brain disease due to the prevalence of its recurrence. Considerable evidence suggests that glioma stem-like cells are responsible for glioma relapse after treatment, which commonly involves ionizing radiation. Here, we found that fractionated ionizing radiation (2 Gy/day for 3 days) induced glioma stem-like cell expansion and resistance to anticancer treatment such as cisplatin (50 μM) or taxol (500 nM), or by ionizing radiation (10 Gy) in both glioma cell lines (U87, U373) and patient-derived glioma cells. Of note, concomitant increase of nitric oxide production occurred with the radiation-induced increase of the glioma stem-like cell population through upregulation of inducible nitric oxide synthase (iNOS). In line with this observation, downregulation of iNOS effectively reduced the glioma stem-like cell population and decreased resistance to anticancer treatment. Collectively, our results suggest that targeting iNOS in combination with ionizing radiation might increase the efficacy of radiotherapy for glioma treatment.
© 2013 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23714583     DOI: 10.1111/cas.12207

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  18 in total

1.  Allergic conditions reduce the risk of glioma: a meta-analysis based on 128,936 subjects.

Authors:  Hongyu Zhao; Weisong Cai; Shitao Su; Debao Zhi; Jie Lu; Shuo Liu
Journal:  Tumour Biol       Date:  2013-12-18

2.  Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance.

Authors:  Anh Nhat Tran; Kiera Walker; David G Harrison; Wei Chen; James Mobley; Lauren Hocevar; James R Hackney; Randee S Sedaka; Jennifer S Pollock; Matthew S Goldberg; Dolores Hambardzumyan; Sara J Cooper; Yancey Gillespie; Anita B Hjelmeland
Journal:  Neuro Oncol       Date:  2018-07-05       Impact factor: 12.300

Review 3.  NOS Expression and NO Function in Glioma and Implications for Patient Therapies.

Authors:  Anh N Tran; Nathaniel H Boyd; Kiera Walker; Anita B Hjelmeland
Journal:  Antioxid Redox Signal       Date:  2016-08-25       Impact factor: 8.401

4.  Antagonistic Effects of Endogenous Nitric Oxide in a Glioblastoma Photodynamic Therapy Model.

Authors:  Jonathan M Fahey; Joseph V Emmer; Witold Korytowski; Neil Hogg; Albert W Girotti
Journal:  Photochem Photobiol       Date:  2016-10-17       Impact factor: 3.421

Review 5.  Gasotransmitters in cancer: from pathophysiology to experimental therapy.

Authors:  Csaba Szabo
Journal:  Nat Rev Drug Discov       Date:  2015-12-18       Impact factor: 84.694

6.  Radiotherapy and Glioma Stem Cells: Searching for Chinks in Cellular Armor.

Authors:  Seamus P Caragher; Sean Sachdev; Atique Ahmed
Journal:  Curr Stem Cell Rep       Date:  2017-10-02

7.  Role of Nitric Oxide in Glioblastoma Therapy: Another Step to Resolve the Terrible Puzzle ?

Authors:  R Altieri; M Fontanella; A Agnoletti; P P Panciani; G Spena; E Crobeddu; G Pilloni; V Tardivo; M Lanotte; F Zenga; A Ducati; D Garbossa
Journal:  Transl Med UniSa       Date:  2014-09-01

Review 8.  Modulation of Radiation Response by the Tetrahydrobiopterin Pathway.

Authors:  Rupak Pathak; Amrita K Cheema; Simina M Boca; Kimberly J Krager; Martin Hauer-Jensen; Nukhet Aykin-Burns
Journal:  Antioxidants (Basel)       Date:  2015-01-22

9.  Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.

Authors:  Sergio Granados-Principal; Yi Liu; Maria L Guevara; Elvin Blanco; Dong Soon Choi; Wei Qian; Tejal Patel; Angel A Rodriguez; Joseph Cusimano; Heidi L Weiss; Hong Zhao; Melissa D Landis; Bhuvanesh Dave; Steven S Gross; Jenny C Chang
Journal:  Breast Cancer Res       Date:  2015-02-22       Impact factor: 6.466

10.  Nitric oxide antagonism to glioblastoma photodynamic therapy and mitigation thereof by BET bromodomain inhibitor JQ1.

Authors:  Jonathan M Fahey; Jennifer S Stancill; Brian C Smith; Albert W Girotti
Journal:  J Biol Chem       Date:  2018-02-12       Impact factor: 5.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.